Letaplimab (IBI-188) is a humanized IgG4 class antibody targeting CD47 and is often used in combination with azacitidine for the treatment of primary diagnosis of intermediate- to high-risk myelodysplastic syndromes.
Purity:
>95.0%
CAS Number:
[2283356-07-8]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted